کد مقاله کد نشریه سال انتشار مقاله انگلیسی ترجمه فارسی نسخه تمام متن
5630489 1580612 2018 14 صفحه PDF سفارش دهید دانلود کنید
عنوان انگلیسی مقاله ISI
Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous system
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI
فقط 3 هزار تومان
سفارش ترجمه تخصصی
با تضمین قیمت و کیفیت
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی عصب شناسی
پیش نمایش صفحه اول مقاله
Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous system
چکیده انگلیسی


- Etazolate enhances the release of the neuroprotective protein sAPPα from demyelinated cerebellar slices.
- α-Secretase-induced sAPPα release rescues myelin sheaths from demyelination.
- Etazolate enhances remyelination ex vivo and in vivo.
- Beneficial effects of etazolate are blocked by an α-secretase inhibitor.
- sAPPα protects myelin sheaths from demyelination.

Remyelination is an endogenous regenerative process of myelin repair in the central nervous system (CNS) with limited efficacy in demyelinating disorders. As strategies enhancing endogenous remyelination become a therapeutic challenge, we have focused our study on α-secretase-induced sAPPα release, a soluble endogenous protein with neuroprotective and neurotrophic properties. However, the role of sAPPα in remyelination is not known. Therefore, we investigated the remyelination potential of α-secretase-induced sAPPα release following CNS demyelination in mice. Acute demyelination was induced by feeding mice with cuprizone (CPZ) for 5 weeks. To test the protective effect and the remyelination potential of etazolate, an α-secretase activator, we designed two treatment protocols. Etazolate was administrated either during the last two weeks or at the end of the CPZ intoxication. In both protocols, etazolate restored the number of myelinated axons in corpus callosum with a corresponding increase in the amount of MBP, one of the major myelin proteins in the brain. We also performed ex vivo studies to decipher etazolate's mechanism of action in a lysolecithin-induced demyelination model using organotypic culture of cerebellar slices. Etazolate treatment was able to i) enhance the release of sAPPα in the culture media of demyelinated slices, ii) protect myelinated axons from demyelination, iii) increase the number of mature oligodendrocytes, iv) promote the reappearance of the paired Caspr+ adjacent to the nodes of Ranvier and v) increase the percentage of myelinated axons with short internodes, an indicator of remyelination. Etazolate failed to promote all the aforementioned effects in the presence of GI254023X, an α-secretase inhibitor. Moreover, the protective effects of etazolate in demyelinated slices were mimicked by sAPPα treatment in a dose-dependent manner. In conclusion, etazolate-induced sAPPα release protects myelinated axons from demyelination while also promoting remyelination. This work, thus, highlights the therapeutic potential of strategies that enhance sAPPα release in demyelinating disorders.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Neurobiology of Disease - Volume 109, Part A, January 2018, Pages 11-24
نویسندگان
, , , , , , , , , , , , ,
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI
فقط 3 هزار تومان
سفارش ترجمه تخصصی
با تضمین قیمت و کیفیت